Evidence map›Paper›PMID 22003031›Full record

ArticleApplied and environmental microbiology2011

Analysis of Clostridium botulinum serotype E strains by using multilocus sequence typing, amplified fragment length polymorphism, variable-number tandem-repeat analysis, and botulinum neurotoxin gene sequencing.

Thomas E Macdonald, Charles H Helma, Yulin Shou, Yolanda E Valdez, Lawrence O Ticknor, Brian T Foley, Stephen W Davis, George E Hannett, Cassandra D Kelly-Cirino, Jason R Barash and 6 more

Open access · greenAbstract read
In one paragraph

Article in Applied and environmental microbiology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed, 1 pooled it
5.8field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 1 synthesis or guideline pooled it, 57 citations in OpenAlex.

  1. Guideline
  2. Whole genome sequencing of neurotoxin-producingFrontiers in public health · 2025
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Impact ofCurrent opinion in food science · 2016
    Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 6 institutions in 2 countries.

Thomas E MacdonaldBioscience Division, Los Alamos National Laboratory, Los Alamos, New Mexico 87545, USA.
Charles H Helma
Yulin Shou
Yolanda E Valdez
Lawrence O Ticknor
Brian T Foley
Stephen W Davis
George E Hannett
Cassandra D Kelly-Cirino
Jason R Barash
Stephen S Arnon
Miia Lindström
Hannu Korkeala
Leonard A Smith
Theresa J Smith
Karen K Hill
Los Alamos National Laboratory · USNew York State Department of Health · USCalifornia Department of Public Health · USUniversity of Helsinki · FIUnited States Army Medical Research and Development Command · USUnited States Department of the Army · US

Funding

PHS HHS IAA B18-120
6 · The paper itself

Abstract

A total of 41 Clostridium botulinum serotype E strains from different geographic regions, including Canada, Denmark, Finland, France, Greenland, Japan, and the United States, were compared by multilocus sequence typing (MLST), amplified fragment length polymorphism (AFLP) analysis, variable-number tandem-repeat (VNTR) analysis, and botulinum neurotoxin (bont) E gene sequencing. The strains, representing environmental, food-borne, and infant botulism samples collected from 1932 to 2007, were analyzed to compare serotype E strains from different geographic regions and types of botulism and to determine whether each of the strains contained the transposon-associated recombinase rarA, involved with bont/E insertion. MLST examination using 15 genes clustered the strains into several clades, with most members within a cluster sharing the same BoNT/E subtype (BoNT/E1, E2, E3, or E6). Sequencing of the bont/E gene identified two new variants (E7, E8) that showed regions of recombination with other E subtypes. The AFLP dendrogram clustered the 41 strains similarly to the MLST dendrogram. Strains that could not be differentiated by AFLP, MLST, or bont gene sequencing were further examined using three VNTR regions. Both intact and split rarA genes were amplified by PCR in each of the strains, and their identities were confirmed in 11 strains by amplicon sequencing. The findings suggest that (i) the C. botulinum serotype E strains result from the targeted insertion of the bont/E gene into genetically conserved bacteria and (ii) recombination events (not random mutations) within bont/E result in toxin variants or subtypes within strains.

Indexed as

Polymorphism, GeneticBotulinum ToxinsBotulismClostridium botulinum type ECluster AnalysisDNA, BacterialDNA Transposable ElementsEnvironmental MicrobiologyFood MicrobiologyGenotypeHumansMolecular Sequence DataMolecular TypingRecombination, GeneticSequence Analysis, DNABotulinum Toxinsbotulinum toxin type EDNA, BacterialDNA Transposable Elements

Identifiers

PMID22003031
PMCPMC3233090
OpenAlexW1965556555

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.